Drug Type CAR-T |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism BCMA modulators(B-cell maturation protein modulators), CST6 inhibitors(cystatin E/M inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Myeloma | Preclinical | United States | 27 Apr 2025 |





